Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUPPORT-pVAD: Inhaled nitric oxide in cardiogenic shock patients supported with percutaneous ventricular assist device
jRCT1061230015Recruiting
- Sponsor
- The Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research
- Start
- Mar 2025
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of nitric oxide in cardiogenic shock (2 arms), sponsored by The Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research. Primary endpoint: Change in cardiac index. Started Mar 2025; status: recruiting.
02
Drugs
nitric oxide
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on jRCT1061230015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061230015.